Targeting cathepsin S induces tumor cell autophagy via the EGFR-ERK signaling pathway

Area of Science:

• Molecular Biology
• Cancer Research
• Cellular Signaling

Background:

• Cathepsin S, a cysteine protease, is over-expressed in human cancers and implicated in tumor metastasis.
• The precise role of cathepsin S in regulating cancer cell survival and death pathways is not fully understood.

Purpose of the Study:

• To investigate whether inhibiting cathepsin S can induce autophagy and apoptosis in cancer cells.
• To elucidate the signaling pathways involved in cathepsin S-mediated regulation of cell death.

Main Methods:

• Utilized specific small molecular inhibitors and cathepsin S siRNA to target cathepsin S activity.
• Analyzed the induction of autophagy and apoptosis in human cancer cells.
• Investigated the involvement of the epidermal growth factor receptor (EGFR) and ERK/MAPK signaling pathway.

Main Results:

• Inhibition of cathepsin S effectively induced both autophagy and subsequent apoptosis in cancer cells.
• The observed autophagy induction was dependent on the phosphorylation of EGFR.
• Activation of the EGFR-related ERK/MAPK signaling pathway was crucial for cathepsin S-targeted autophagy.

Conclusions:

• Cathepsin S plays a significant role in regulating cancer cell autophagy.
• Cathepsin S influences autophagy by interfering with the EGFR-ERK/MAPK signaling cascade.
• Targeting cathepsin S presents a potential therapeutic strategy for cancer treatment by inducing cell death.